Lilly Asia Ventures
Shanghailillyasiacap.com
Overview
Lilly Asia Ventures is a venture capital firm founded in 2008 that invests in the life sciences and healthcare sectors, including biopharmaceuticals, medical devices, and diagnostics, primarily in Asia and the United States.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Avenzo Therapeutics | Sep 2025 | Series B | Co-investor |
| Cornerstone Robotics | Jan 2025 | Series C | Co-investor |
| Timberlyne Therapeutics | Jan 2025 | Series A | Co-investor |
| Avenzo Therapeutics | Nov 2024 | Series A | Co-investor |
| IMPACT Therapeutics | Apr 2024 | Series D Extension | Co-investor |
Key People
Stella Shi
Founder, CEO
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
